glycine propionyl l-carnitine GPLC (glycine propionyl-L-carnitine) nutritional supplement molecule. Atoms are represented as spheres with conventional color coding: hydrogen (whit Stock Photo GPLC nutritional supplement molecule, illustration

Immune dysregulation due to evasion strategies or host factors facilitates disease progression and drug resistance

CodY is a global transcriptional regulator required for virulence in group B streptococcus

Redox Biol 46:102122 Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne CD, Castro Narro GE, Chowdhury A, Cortez-Pinto H, Cryer DR, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot BG, Korenjak M, Kowdley KV, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TR, Powell EE, Roden M, Romero-Gmez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wong VW, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, Newsome PN, NAFLD Nomenclature consensus group (2023) A multisociety Delphi consensus statement on new fatty liver disease nomenclature

For example, baricitinib acts as a selective inhibitor of JAK1 and JAK2, and in a clinical trial evaluating type 2 diabetic adults at high risk of progressive DN, baricitinib was found to significantly reduce albuminuria, thereby improving DN (13)

Global Health Data Exchange (GHDx), ( (accessed November 12, 2023)